Related Experiment Videos
[Juvenile chronic arthritis]
Insights
Juvenile chronic arthritis (JCA) is a common childhood connective tissue disease with unpredictable outcomes. Early diagnosis and multidisciplinary management are crucial for improving long-term physical and psychological health in affected children.
Area of Science:
- Pediatric Rheumatology
- Connective Tissue Diseases
- Immunology
Context:
- Juvenile chronic arthritis (JCA) is the most prevalent connective tissue disease in children.
- JCA presents significant social and clinical challenges due to its chronic nature and potential for severe complications like infirmity and blindness.
- Understanding the different onset types (systemic, poliarticular, pauciarticular) is key to JCA management.
Purpose:
- To outline the classification, clinical presentation, and diagnostic criteria for Juvenile Chronic Arthritis.
- To discuss the pharmacological and non-pharmacological treatment strategies for JCA.
- To emphasize the necessity of multidisciplinary care for comprehensive JCA management.
Summary:
- JCA affects large joints and the cervical spine, with systemic onset characterized by fever, rash, and organ involvement.
- Chronic uveitis, often linked to antinuclear antibodies, is a notable feature, particularly in pauciarticular JCA.
- Diagnosis is primarily clinical, utilizing 1977 ARA criteria, with Aspirin being a common treatment, though more toxic drugs may be required in some cases.
Impact:
- Effective management of JCA requires a multidisciplinary approach, integrating pharmacological, orthopedic, and physiotherapeutic interventions.
- Early and appropriate treatment can mitigate the progression of JCA, reducing the risk of long-term disability.
- Multidisciplinary centers are essential for holistic JCA care, supporting both physical and psychological development in affected children.
Abstract:
Juvenile chronic arthritis is the most common connective tissue disease in children. It is of great social and clinical interest for its chronicity, for the often unpredictable response to pharmacological treatment; for the spontaneous evolution toward infirmity and often blindness. The English classification of the disease is here been adopted. There are 3 different types of onset: systemic, poliarticular and pauciarticular. Large joints such as the knees, wrists and ankles are involved more often than small joints. Also the cervical spine is frequently affected. Systemic disease is accompanied by high spiking fever, rash, lynphoadenopathy, pericarditis and hepatosplenomegaly. Chronic uveitis is a feature of JCA, more frequently observed in pauciarticular than in the other types of onset, and it is almost always associated with antinuclear antibody seropositivity. Rheumatoid factor (RF) and subcutaneous nodules are unusual in JCA. Diagnosis is often not easy and it is essentially clinical. The diagnostic criteria adopted have been proposed by ARA in 1977. In the majority of children treatment with ASA is successful. Sometimes other types of more toxic drugs such as gold salts or penicillamine are needed. Their use is best confined to reference centers. Orthopedical and physiotherapic treatments are complementary to the pharmacological one. Multidisciplinary centers are therefore necessary for the total management of these children also to stress the importance of furthering physical and psychological growth.